Report Added
Report already added
Related Report
Abstract
Report Scope:
This research report incorporates an in-depth analysis of the medical device market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, along with market share analysis and ranking in the market. Regulatory landscape analysis focuses on recent regulations in regions such as the U.S., Europe, and Japan.
Report Includes:
- 72 data tables and 113 additional tables
- An up-to-date assessment of the global medical devices market and industry competitive landscape featuring top 50 medical device manufacturers
- Estimation of the actual market size and revenue forecast for global medical devices market in USD million values, with analyses and growth forecasts through 2021
- Discussion of the major market potential and opportunities in medical devices industry, along with a detailed analysis of the competitive environment, regulatory scenario, and recent technological advancements
- In-depth information on increasing investments on research and development (R&D) activities, key technology issues, industry specific challenges, and COVID-19 implications on the progress of medical devices marketplace
- Review of the regulatory landscape for global medical devices manufacturers with emphasis on recent regulations in regions such as the U.S., Europe, and Japan
- Market share analysis of leading medical device manufacturers, their research priorities, global rankings, manufacturers mapping by therapeutic area, and market development strategies
- Company profiles of the leading global corporations in the medical devices industry, including Abbott, Bio-Rad Laboratories Inc., Danaher Corp., General Electric, Medtronic, Olympus Corp., Stryker Corp. and Terumo Corp.
Content
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 What's New in This Update?
1.5 Methodology
1.5.1 Primary Data and Information Gathering
1.5.2 Secondary Data and Information Gathering
1.5.3 Market Revenue Forecasts
1.6 Analyst's Credentials
1.7 BCC Custom Research
1.8 Related BCC Research Reports
Chapter 2 Market and Technology Background
2.1 Background and Definitions: Medical Devices
2.2 Evolution
2.3 Uses of Various Devices
2.4 Types
2.4.1 Imaging Systems
2.4.2 In Vitro Diagnostics
2.4.3 Cardiovascular Disease Procedures
2.4.4 Orthopedic and Spinal Procedures
2.5 Innovations in Medical Devices
2.6 Stakeholders Involved in the Innovation Process
2.7 Medical Device Industry
2.8 Patents and Patent Applications
2.9 Cost of Medical Device Innovation
2.10 Current Trends in the Medical Device Industry
2.10.1 Notable Trends
2.11 Importance of Innovation
2.12 Challenges Facing the Sector
2.12.1 Public Health Systems
2.12.2 Balancing Patient Needs and Financial Sustainability
2.12.3 Competitiveness and Innovation
2.13 Market Dynamics
2.13.1 Drivers
2.13.2 Restraints
2.13.3 Opportunities
2.13.4 Strategic Initiatives by Major Players in the Market
2.13.5 Strategies
2.13.6 Distribution Network
2.13.7 Trends
2.14 New Products and Technologies
2.15 New Materials
2.16 Refurbished and Replacement Market
2.17 Mergers and Acquisitions
2.18 Recommendations
Chapter 3 Impact of COVID-19 on the Medical Device Market
3.1 PPE and Masks
3.2 Testing Equipment
3.3 Syringes and Vaccines
3.4 Ventilators
3.5 Developments
3.5.1 FDA Awards Innovation Permission for System to Prevent People from Mechanical Ventilation
3.5.2 POC Test Platform Uses Smartphone App for Rapid Detection of COVID-19
3.5.3 Collaboration on COVID-19 Molecular Diagnostics Test
3.5.4 Roche to Acquire Diagnostics Test Company
3.5.5 Portable Ultrasound Scanner Enables Physicians to Quickly Triage COVID-19 Patients
3.5.6 QuantuMDx Invests £11 Million to Develop POC COVID-19 Test Device
3.6 Key Factors Underlying the Impact of COVID-19 on the Medical Device Industry
3.6.1 Decline/Delay in Elective Procedures
3.6.2 Supply Chain Disruptions
3.6.3 Strong Impact on China
3.6.1 Impact of COVID-19 on Medical Device Product Segments
3.7 Key Takeaways
Chapter 4 Regulatory Structure: Medical Devices
4.1 Regulatory Background
4.2 Regulatory Systems for Medical Devices, by Region/Country
4.2.1 U.S.
4.2.2 European Union (EU)
4.2.3 Japan
Chapter 5 Medical Devices Industry: Competitive Landscape
5.1 Overview
5.2 Key Strategies of Major Medical Device Manufacturers
5.2.1 Distribution Networks
5.2.2 Trends
5.2.3 New Products and Technologies
5.2.4 Mergers and Acquisitions
5.2.5 Recommendations
5.3 Key Developments of Major Medical Device Manufacturers
Chapter 6 Company Profiles
3M
ABBOTT
ALCON INC.
ALIGN TECHNOLOGY INC.
B. BRAUN MELSUNGEN AG
BAXTER
BECTON, DICKINSON AND CO.
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
BOSTON SCIENTIFIC CORP.
BRUKER
CANON INC.
CARDINAL HEALTH
CARL ZEISS AG
COLOPLAST GROUP
CONVATEC GROUP PLC
THE COOPER COMPANIES INC.
DANAHER CORP.
DEMANT A/S
DENTSPLY SIRONA
DRAGERWERK AG & CO. KGAA
DEXCOM INC.
EDWARDS LIFESCIENCES CORP.
ESSILORLUXOTTICA SA
F. HOFFMANN-LA ROCHE LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
FUJIFILM HOLDINGS CORP.
GENERAL ELECTRIC
GETINGE AB
HARVARD BIOSCIENCE INC.
HOYA CORP.
HITACHI LTD.
HOLOGIC INC.
INSTITUT STRAUMANN AG
INTEGRA LIFESCIENCES HOLDINGS CORP.
INTUITIVE SURGICAL
JOHNSON & JOHNSON SERVICES INC.
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
MICROPORT SCIENTIFIC CORP.
NIHON KOHDEN CORP.
NIPRO
OLYMPUS CORP.
PAUL HARTMANN AG
RESMED INC.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
SHIP HEALTHCARE HOLDINGS INC.
SIEMENS HEALTHCARE AG
SMITH & NEPHEW
STERIS PLC
SONOVA
STRYKER CORP.
SYSMEX CORP.
TELEFLEX INC.
TERUMO CORP.
VARIAN MEDICAL SYSTEMS INC.
WEST PHARMACEUTICAL SERVICES INC.
ZIMMER BIOMET
List of Tables:
Table 1 : U.S. FDA Cleared or Approved Medical Devices, 2021 and 2022
Table 2 : U.S. FDA Cleared or Approved Medical Devices, 2018
Table 3 : Medical Device Codes
Table 4 : Global Medical Device Market Size, by Region, Through 2027
Table 5 : EPO Patents and Patent Applications on Industry Technologies, by Type, 2018
Table 6 : Leading Companies in Published Patent Applications on Medical Devices, 2018-2022
Table 7 : Top 20 Medical Device Companies in Granted Patents, 2020 and 2021
Table 8 : Leading Countries Granted Medical Device Patents, 2018-2022
Table 9 : U.S. Patents on Medical Device Technologies
Table 10 : European Patents on Medical Device Technologies
Table 11 : Japanese Patents on Medical Device Technologies
Table 12 : Top 20 Medical Device Companies: R&D Expenditures, 2021
Table 13 : Leading Companies in the Global Medical Device Market, 2021
Table 14 : Class I and Class II Exempted Devices from Premarket Approval
Table 15 : Medical Device User Fee Amendments (MDUFA), 2020
Table 16 : Regulatory Approval: U.S. versus Europe
Table 17 : Global Medical Device Manufacturers Ranking, by Revenue, 2021
Table 18 : Select Product Launches and Approvals in the Medical Device Market, 2013-2022
Table 19 : Mergers and Acquisitions in the Medical Devices Market, 2022
Table 20 : Agreements, Joint Ventures, Expansions, Divestments, and Investments in the Medical Devices Market, 2019-2022
Table 21 : Analysis of Leading Companies in the Global Medical Devices Market, 2021
Table 22 : 3M: Products and Services
Table 23 : 3M: Financials, 2021
Table 24 : 3M: Recent Developments, 2022
Table 25 : Abbott: Financials, 2016-2021
Table 26 : Abbott: Product Portfolio, by Business Segment
Table 27 : Abbott: Recent Developments, 2015-2022
Table 28 : Alcon Inc.: Financials, 2021
Table 29 : Alcon Inc.: Recent Developments, 2016-2020
Table 30 : Align Technology Inc.: Key Financials, 2021
Table 31 : Align Technology Inc.: Products Offered
Table 32 : Align Technology Inc.: Key Developments, 2022
Table 33 : B. Braun Melsungen AG: Products
Table 34 : B. Braun Melsungen AG: Financials, 2021
Table 35 : B. Braun Melsungen AG: Developments and Strategies, 2022
Table 36 : Baxter: Product Portfolio
Table 37 : Baxter: Financials, 2021
Table 38 : Baxter: Parenteral Nutrition Products
Table 39 : Baxter: Recent Developments, 2015-2022
Table 40 : Becton, Dickinson and Co.: Financials, 2021
Table 41 : Becton, Dickinson and Co.: Product Portfolio
Table 42 : Becton, Dickinson and Co.: Bioscience Cell Culture Product Portfolio
Table 43 : Becton, Dickinson and Co.: Recent Developments, 2015-2022
Table 44 : BioMerieux: Financials, 2021
Table 45 : BioMerieux: Products and Services
Table 46 : BioMerieux: Recent Developments, 2018-2020
Table 47 : Bio-Rad Laboratories Inc.: Financials, 2021
Table 48 : Bio-Rad Laboratories Inc.: Products and Services
Table 49 : Bio-Rad Laboratories Inc.: Recent Developments, 2018 and 2019
Table 50 : Boston Scientific Corp.: Product Portfolio
Table 51 : Boston Scientific Corp.: Financials, 2016-2021
Table 52 : Boston Scientific Corp.: Cardiac Rhythm Management Products, 2021
Table 53 : Boston Scientific Corp.: Recent Developments, 2022
Table 54 : Bruker: Products
Table 55 : Bruker: Financials, 2021
Table 56 : Bruker: Recent Developments, 2018-2020
Table 57 : Canon Medical Systems Corp.: Product Portfolio
Table 58 : Canon Medical Systems Corp.: Financials, 2021
Table 59 : Canon Medical Systems Corp.: Recent Developments, 2016-2022
Table 60 : Cardinal Health: Product Portfolio
Table 61 : Cardinal Health: Financials, 2021
Table 62 : Cardinal Health: Recent Developments, 2013-2022
Table 63 : Carl Zeiss AG: Financials, 2021
Table 64 : Carl Zeiss AG: Recent Developments, 2022
Table 65 : Coloplast Group: Product Portfolio
Table 66 : Coloplast Group: Financials, 2021
Table 67 : Coloplast Group: Recent Developments, 2022
Table 68 : ConvaTec: Financials, 2021
Table 69 : ConvaTec: Product Portfolio, by Business Segment
Table 70 : ConvaTec: Recent Developments, 2017-2022
Table 71 : The Cooper Companies Inc.: Financials, 2021
Table 72 : The Cooper Companies Inc.: Product Portfolio, by Business Segment
Table 73 : The Cooper Companies Inc.: Recent Developments, 2017-2019
Table 74 : Danaher Corp.: Product Portfolio
Table 75 : Danaher Corp.: Financials, 2021
Table 76 : Danaher Corp.: Products and Services
Table 77 : Danaher Corp.: Recent Developments, 2015-2021
Table 78 : Demant: Product Portfolio
Table 79 : Demant: Financials, 2021
Table 80 : Demant: Developments and Strategies
Table 81 : Dentsply Sirona: Financials, 2021
Table 82 : Dentsply Sirona: Products and Services
Table 83 : Drägerwerk AG & Co. KGaA: Financials, 2021
Table 84 : Drägerwerk AG & Co. KGaA: Product Portfolio
Table 85 : Drägerwerk AG & Co. KGaA: Recent Developments and Strategies, 2015-2020
Table 86 : Dexcom Inc.: Financials, 2021
Table 87 : Edwards Lifesciences Corp.: Financials, 2021
Table 88 : Edwards Lifesciences Corp.: Revenue, by Product Segment, 2018-2019
Table 89 : Edwards Lifesciences Corp.: Recent Developments, 2017-2019
Table 90 : EssilorLuxottica SA: Product Portfolio
Table 91 : EssilorLuxottica SA: Financials, 2021
Table 92 : EssilorLuxottica SA: Developments and Strategies, 2015-2018
Table 93 : Roche: Financials, 2021
Table 94 : Roche: Revenue, by Business Segment, 2016-2021
Table 95 : Roche: Revenue, by Diagnostic Segment, 2016-2021
Table 96 : Roche: Product Portfolio
Table 97 : Roche: Diagnostics Patient Monitoring Product Portfolio
Table 98 : Roche: Recent Developments, 2015-2022
Table 99 : Fresenius Medical Care: Product Portfolio
Table 100 : Fresenius Medical Care: Financials, 2021
Table 101 : Fresenius Medical Care: Recent Developments, 2015-2020
Table 102 : FujiFilm Holdings Corp.: Financials, 2021
Table 103 : FujiFilm Holdings Corp.: Product Portfolio
Table 104 : General Electric: Financials, 2021
Table 105 : GE Healthcare: Product Portfolio
Table 106 : GE Healthcare: Recent Developments, 2015-2022
Table 107 : Getinge AB: Financials, 2021
Table 108 : Getinge AB: Recent Developments, 2021
Table 109 : Harvard Bioscience Inc.: Financials, 2017-2019
Table 110 : Harvard Bioscience Inc.: Product Information, 2018
Table 111 : Harvard Biosciences Inc.: Recent Developments, 2018
Table 112 : Hoya Corp.: Financials, 2021
Table 113 : Hitachi Medical Corp.: Medical Device Products and Services
Table 114 : Hitachi Medical Corp.: Financials, 2021
Table 115 : Hitachi: Key Developments and Strategies, 2016-2021
Table 116 : Hologic Inc.: Financials, 2021
Table 117 : Hologic Inc.: Developments and Strategies, 2017-2020
Table 118 : Institut Straumann AG: Financials, 2021
Table 119 : Institut Straumann AG: Product Portfolio
Table 120 : Integra LifeSciences Holdings Corp.: Financials, 2021
Table 121 : Integra LifeSciences Holdings Corp.: Product Portfolio
Table 122 : Integra LifeSciences Holdings Corp.: Developments and Strategies, 2016-2019
Table 123 : Intuitive Surgical: Financials, 2021
Table 124 : Intuitive Surgical: Revenue, by Product Segment, 2016-2019
Table 125 : Intuitive Surgical: Recent Developments, 2017-2019
Table 126 : Johnson & Johnson: Financials, 2021
Table 127 : Johnson & Johnson: Product Portfolio
Table 128 : Johnson & Johnson: Recent Developments and Strategies, 2017-2022
Table 129 : Koninklijke Philips: Product Portfolio
Table 130 : Koninklijke Philips: Financials, 2021
Table 131 : Koninklijke Philips: Recent Developments, 2015-2022
Table 132 : Medtronic: Financials, 2016-2022
Table 133 : Medtronic: Product Portfolio
Table 134 : Medtronic: Patient Monitoring Device Product Portfolio
Table 135 : Medtronic: Recent Developments, 2015-2022
Table 136 : MicroPort Scientific Corp.: Financials, 2021
Table 137 : MicroPort Scientific Corp.: Marketed CRM Products, 2018
Table 138 : MicroPort Scientific Corp.: Recent Developments, 2019-2020
Table 139 : Nihon Kohden Corp.: Product Portfolio, by Business Segment
Table 140 : Nihon Kohden Corp.: Financials, 2021
Table 141 : Nipro Group: Financials, 2021
Table 142 : Nipro Group: Product Portfolio, by Business Segment
Table 143 : Nipro Group: Recent Developments, 2020
Table 144 : Olympus Corp.: Product Portfolio
Table 145 : Olympus Corp.: Financials, 2021
Table 146 : Olympus Corp.: Recent Developments, 2020
Table 147 : Paul Hartmann: Financials, 2021
Table 148 : Paul Hartmann: Key Product Portfolio
Table 149 : ResMed Inc.: Products and Services
Table 150 : ResMed Inc.: Financials, 2021
Table 151 : ResMed Inc.: Key Developments and Strategies, 2020
Table 152 : Mindray: Financials, 2021
Table 153 : Mindray: Selected Recent Developments, 2019-2021
Table 154 : Ship Healthcare: Financials, 2021
Table 155 : Siemens Healthcare AG: Key Products
Table 156 : Siemens Healthcare AG: Product Segments
Table 157 : Siemens Healthcare AG: Financials, 2021
Table 158 : Siemens Healthcare AG: Key Developments, 2022
Table 159 : Smith & Nephew: Financials, 2021
Table 160 : Smith & Nephew: Product Portfolio
Table 161 : Smith & Nephew: Recent Developments, 2015-2017
Table 162 : Steris: Financials, 2021
Table 163 : Steris: Developments and Strategies, 2021
Table 164 : Sonova: Product Portfolio
Table 165 : Sonova: Financials, 2021
Table 166 : Sonova: Developments and Strategies, 2015-2020
Table 167 : Stryker Corp.: Product Portfolio
Table 168 : Stryker Corp.: Financials, 2021
Table 169 : Stryker Corp.: Developments and Strategies, 2015-2022
Table 170 : Sysmex Corp.: Financials, 2021
Table 171 : Sysmex Corp.: Products and Services
Table 172 : Sysmex Corp.: Recent Developments, 2019-2020
Table 173 : Teleflex Inc.: Financials, 2021
Table 174 : Teleflex Inc.: Product Portfolio
Table 175 : Teleflex Inc.: Recent Developments, 2015-2020
Table 176 : Terumo Corp.: Financials, 2021
Table 177 : Terumo Corp.: Recent Developments, 2020
Table 178 : Varian Medical Systems Inc.: Financials, 2021
Table 179 : Varian Medical Systems Inc.: Product Portfolio, by Business Segment
Table 180 : Varian Medical Systems Inc.: Recent Developments, 2014-2020
Table 181 : West Pharmaceutical Services Inc.: Financials, 2021
Table 182 : West Pharmaceutical Services Inc.: Product Portfolio
Table 183 : Zimmer Biomet: Product Portfolio
Table 184 : Zimmer Biomet: Financials, 2021
Table 185 : Zimmer Biomet: Developments and Strategies, 2014-2019
Related Report